M
Miguel Ingelmo
Researcher at University of Barcelona
Publications - 169
Citations - 14818
Miguel Ingelmo is an academic researcher from University of Barcelona. The author has contributed to research in topics: Lupus erythematosus & Antiphospholipid syndrome. The author has an hindex of 64, co-authored 169 publications receiving 14022 citations. Previous affiliations of Miguel Ingelmo include Benemérita Universidad Autónoma de Puebla.
Papers
More filters
Journal ArticleDOI
Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
Ricard Cervera,J.C. Piette,Josep Font,Munther A. Khamashta,Yehuda Shoenfeld,María Teresa Camps,Søren Jacobsen,Gabriella Lakos,Angela Tincani,Irene Kontopoulou-Griva,Mauro Galeazzi,Pier Luigi Meroni,Ronald H. W. M. Derksen,Philip G. de Groot,Erika Gromnica-Ihle,Marta Baleva,Marta Mosca,Stefano Bombardieri,Frédéric Houssiau,Jean-Christophe Gris,Isabelle Quéré,Eric Hachulla,Carlos Vasconcelos,B. Roch,Antonio Fernández-Nebro,Marie Claire Boffa,Graham R. V. Hughes,Miguel Ingelmo +27 more
TL;DR: An association with SLE, the patient's sex, and the patient’s age at disease onset can modify the disease expression and define specific subsets of APS.
Journal ArticleDOI
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients
Ricard Cervera,Munther A. Khamashta,Josep Font,Gian Domenico Sebastiani,Antonio Gil,Lavilla P,Juan Carlos Mejía,A. Olcay Aydintug,Hanna Chwalinska-Sadowska,Enrique de Ramón,Antonio Fernández-Nebro,Mauro Galeazzi,Merete Valen,Alessandro Mathieu,Frédéric Houssiau,Natividad Caro,Paula Alba,Manuel Ramos-Casals,Miguel Ingelmo,Graham R. V. Hughes +19 more
TL;DR: In this paper, the authors assessed the frequency and characteristics of the main causes of morbidity and mortality in systemic lupus erythematosus (SLE) during a 10-year period and compared the frequency of early manifestations with those that appeared later in the evolution of the disease.
Journal ArticleDOI
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients.
Ronald A. Asherson,Ricard Cervera,Jean-Charles Piette,Josep Font,J. T. Lie,Arsinur Burcoglu,Ken Lim,Francisco J. Muñoz-Rodríguez,Roger A. Levy,François Boué,Jérôme Rossert,Miguel Ingelmo +11 more
TL;DR: The majority of patients manifested microangiopathy--that is, occlusive vascular disease affecting predominantly small vessels of organs, particularly kidney, lungs, brain, heart, and liver--with a minority of patients experiencing only large vessel occlusions.
Journal ArticleDOI
Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patients☆
J. L. Vianna,Munther A. Khamashta,José Ordi-Ros,José Font,Ricard Cervera,Alfonso López-Soto,Carlos Tolosa,Juliane Franz,Alberto Selva,Miguel Ingelmo,Miguel Vilardell,Graham R. V. Hughes +11 more
TL;DR: Patients with APs plus SLE and PAPS have similar clinical profiles, although heart valve disease, hemolytic anemia, low C4 levels, and neutropenia seem to be more common in patients with APSplus SLE.
Journal ArticleDOI
The epidemiology of systemic lupus erythematosus.
TL;DR: The most important data regarding the incidence and prevalence of systemic lupus erythematosus in the general population, the epidemiologic information on the patterns of disease expression in specific subsets and the studies on mortality in SLE are reviewed.